NO20044005L - HFA Suspension Formulation Containing An Anticholinergic - Google Patents

HFA Suspension Formulation Containing An Anticholinergic

Info

Publication number
NO20044005L
NO20044005L NO20044005A NO20044005A NO20044005L NO 20044005 L NO20044005 L NO 20044005L NO 20044005 A NO20044005 A NO 20044005A NO 20044005 A NO20044005 A NO 20044005A NO 20044005 L NO20044005 L NO 20044005L
Authority
NO
Norway
Prior art keywords
anticholinergic
hfa
formulation containing
suspension formulation
hfa suspension
Prior art date
Application number
NO20044005A
Other languages
Norwegian (no)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28050989&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20044005(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20044005L publication Critical patent/NO20044005L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Suspensions of crystalline tiotropium bromide monohydrate (I) in the propellant gases HFA 227 and/or HFA 134a, optionally mixed with one or more further propellant gases selected from propane, butane, pentane, dimethyl ether, difluoromonochloromethane, difluoromethane, isobutane, isopentane and/or neopentane, are new. ACTIVITY : Antiasthmatic; Antiinflammatory. MECHANISM OF ACTION : Anticholinergic.
NO20044005A 2002-03-28 2004-09-23 HFA Suspension Formulation Containing An Anticholinergic NO20044005L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214263A DE10214263A1 (en) 2002-03-28 2002-03-28 HFA suspension formulations containing an anticholinergic
PCT/EP2003/002898 WO2003082252A1 (en) 2002-03-28 2003-03-20 Hfa-suspension formulations containing an anticholinergic

Publications (1)

Publication Number Publication Date
NO20044005L true NO20044005L (en) 2004-10-05

Family

ID=28050989

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044005A NO20044005L (en) 2002-03-28 2004-09-23 HFA Suspension Formulation Containing An Anticholinergic

Country Status (27)

Country Link
EP (2) EP1492513B1 (en)
JP (1) JP4480401B2 (en)
KR (1) KR101066801B1 (en)
CN (1) CN1329023C (en)
AT (1) ATE339953T1 (en)
AU (1) AU2003209743B2 (en)
BR (1) BR0308764A (en)
CA (1) CA2479640C (en)
CY (1) CY1105543T1 (en)
DE (2) DE10214263A1 (en)
DK (1) DK1492513T3 (en)
EA (1) EA007239B1 (en)
EC (1) ECSP045321A (en)
ES (1) ES2273020T3 (en)
HK (1) HK1079091A1 (en)
HR (1) HRP20040889B1 (en)
IL (2) IL163697A0 (en)
ME (1) ME00247B (en)
MX (1) MXPA04009337A (en)
NO (1) NO20044005L (en)
NZ (1) NZ536043A (en)
PL (1) PL371296A1 (en)
PT (1) PT1492513E (en)
RS (1) RS52178B (en)
UA (1) UA78557C2 (en)
WO (1) WO2003082252A1 (en)
ZA (1) ZA200405638B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005259523B2 (en) † 2004-07-02 2011-06-09 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant
TWI396541B (en) * 2005-10-10 2013-05-21 Boehringer Ingelheim Int Novel combinations of medicaments for the treatment of respiratory diseases
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
GB201200504D0 (en) * 2011-12-19 2012-02-22 Teva Branded Pharmaceutical Prod R & D Inc An inhaler
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
CN104918604A (en) * 2012-10-23 2015-09-16 西普拉有限公司 Pharmaceutical composition
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN107056629B (en) * 2017-04-27 2019-04-30 河北科技大学 A kind of preparation method of anhydrous halogenation choline and its derivative monocrystalline

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
WO2000007567A1 (en) * 1998-08-04 2000-02-17 Jago Research Ag Medicinal aerosol formulations
DZ2947A1 (en) * 1998-11-25 2004-03-15 Chiesi Farma Spa Pressure metered dose inhaler.
DE19921693A1 (en) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
IT1317846B1 (en) * 2000-02-22 2003-07-15 Chiesi Farma Spa FORMULATIONS CONTAINING AN ANTICOLINERGIC DRUG FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE BRONCOPNEUMOPATHY.
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
NZ525733A (en) * 2000-10-12 2005-01-28 Boehringer Ingelheim Pharma Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
WO2002036106A2 (en) * 2000-10-31 2002-05-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel medicament compositions based on anticholinergics and corticosteroids
DE10056104A1 (en) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Drug compositions useful for treatment of respiratory diseases, especially asthma and chronic obstructive pulmonary disease comprises tiotropium salts and salmeterol salts

Also Published As

Publication number Publication date
IL163697A0 (en) 2005-12-18
ECSP045321A (en) 2005-01-28
CA2479640C (en) 2010-09-28
BR0308764A (en) 2005-01-11
MEP47408A (en) 2011-02-10
AU2003209743A1 (en) 2003-10-13
YU85904A (en) 2006-08-17
ZA200405638B (en) 2005-07-27
EP1695701A3 (en) 2010-04-28
ATE339953T1 (en) 2006-10-15
NZ536043A (en) 2005-09-30
EA007239B1 (en) 2006-08-25
AU2003209743B2 (en) 2008-03-06
PL371296A1 (en) 2005-06-13
WO2003082252A1 (en) 2003-10-09
RS52178B (en) 2012-10-31
EP1695701B1 (en) 2015-01-07
HK1079091A1 (en) 2006-03-31
JP2005529087A (en) 2005-09-29
CY1105543T1 (en) 2010-07-28
IL163697A (en) 2011-03-31
KR20040098031A (en) 2004-11-18
CN1329023C (en) 2007-08-01
DE50305118D1 (en) 2006-11-02
ME00247B (en) 2011-05-10
HRP20040889B1 (en) 2012-11-30
CA2479640A1 (en) 2003-10-09
EP1695701A2 (en) 2006-08-30
DK1492513T3 (en) 2006-12-18
DE10214263A1 (en) 2003-10-16
HRP20040889A2 (en) 2004-12-31
PT1492513E (en) 2006-12-29
CN1642534A (en) 2005-07-20
JP4480401B2 (en) 2010-06-16
MXPA04009337A (en) 2005-01-25
EA200401190A1 (en) 2005-04-28
ES2273020T3 (en) 2007-05-01
UA78557C2 (en) 2007-04-10
EP1492513A1 (en) 2005-01-05
EP1492513B1 (en) 2006-09-20
KR101066801B1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
HK1079091A1 (en) Hfa-suspension formulations containing an anticholinergic
CA2107232A1 (en) Azeotropic and azeotrope-like compositions of 1,1,2,2-tetrafluoroethane
JP2008036429A5 (en)
ES2156412T3 (en) BLENDS WITH 1,1,1,3,3-PENTAFLUOROBUTAN.
ATE164864T1 (en) PROpellants CONTAINING LIQUID CARBON DIOXIDE
WO2005048976A3 (en) Foams comprising a sclerosing and a viscosity enhancing agent, methods for production thereof
EP2036943A3 (en) Compositions containing fluorine substituted olefins
DE69522441D1 (en) COMPOSITIONS FROM HYDROCARBONS
CA2148854A1 (en) Near-azeotropic blends for use as refrigerants
AU2001277096A1 (en) Monolithic expandable structures, methods of manufacture and composite structures
TW200639202A (en) Class fiber reinforced polyurethane/polyisocyanurate foam
ZA200100408B (en) Medicinal aerosol formulations.
CY1111089T1 (en) REFRIGERATOR COMPOSITION
HK1087429A1 (en) Chiller refrigerants
BRPI0713310A2 (en) cell size enhancers for polystyrene foams
MX2007007550A (en) Flame retardant expanded polystyrene foam compositions.
ATE96836T1 (en) AZEOTROPS OF HYDROGEN CARBONS WITH BUTANES.
BR9808818A (en) Composition consisting essentially of 1, 1, 1, 3, 3-pentafluorobutane and a hydrocarbon, use of azeotropic or pseudo-azeotropic compositions, foaming agent for polymeric cell foams and premix for polyurethane foam.
EP0626421A4 (en) Blowing agent composition, production of foam using said composition, and foam produced thereby.
DK0632090T3 (en) Process for foaming fire-retardant styrene polymerates
CA2305777A1 (en) High productivity, low fugitive voc emission foam process
DK0552075T3 (en) Mixtures of 1,1,1-trifluoroethane and perfluoropropane and their use as refrigerants, aerosol propellants or plastic foam expansion agents
NO953675L (en) Azeotrope-like mixtures of 1,1,1,2,3,3,3-heptafluoro propane and 1,1-difluoroethane, and the use of such
MX2007007549A (en) Flame retardant polystyrene foam compositions.
MXPA01009294A (en) Azeotropeminus;like compositions of pentafluoropropane, hydrocarbons and water.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application